BAP1 and nonpapillary renal cell carcinoma: In ccRCC, VHL mutations occur at ∼75%, and SETD2 and BAP1 at 10–20% frequencies21, whereas in our uRCC cohort, only a single VHL mutation was detected in one case (T08).